BEPOTASTINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Bepotastine, and when can generic versions of Bepotastine launch?
Bepotastine is a drug marketed by Alembic, Apotex, Mylan, and Somerset Theraps Llc. and is included in four NDAs.
The generic ingredient in BEPOTASTINE is bepotastine besilate. There are seven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bepotastine besilate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Bepotastine
A generic version of BEPOTASTINE was approved as bepotastine besilate by MYLAN on March 18th, 2019.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BEPOTASTINE?
- What are the global sales for BEPOTASTINE?
- What is Average Wholesale Price for BEPOTASTINE?
Summary for BEPOTASTINE
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Drug Prices: | Drug price information for BEPOTASTINE |
| DailyMed Link: | BEPOTASTINE at DailyMed |
US Patents and Regulatory Information for BEPOTASTINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alembic | BEPOTASTINE BESILATE | bepotastine besilate | SOLUTION/DROPS;OPHTHALMIC | 214588-001 | Apr 5, 2023 | AT | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Somerset Theraps Llc | BEPOTASTINE BESILATE | bepotastine besilate | SOLUTION/DROPS;OPHTHALMIC | 217770-001 | Aug 14, 2024 | AT | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Apotex | BEPOTASTINE BESILATE | bepotastine besilate | SOLUTION/DROPS;OPHTHALMIC | 206066-001 | Mar 5, 2019 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mylan | BEPOTASTINE BESILATE | bepotastine besilate | SOLUTION/DROPS;OPHTHALMIC | 206220-001 | Mar 18, 2019 | AT | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
